Processa Pharmaceuticals, Inc.
Clinical-stage biopharma developing treatments for oncology and chronic diseases.
PCSA | US
Overview
Corporate Details
- ISIN(s):
- US74275C2052
- LEI:
- Country:
- United States of America
- Address:
- 601 21ST STREET, SUITE 300, 32960 VERO BEACH
- Sector:
- Manufacturing
Description
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for patients with unmet medical needs in life-threatening and chronic diseases. The company's primary area of development is oncology, where it aims to improve the safety and efficacy of existing chemotherapy drugs through its Next Generation Cancer (NGC) therapies. Its pipeline includes PCS6422 for metastatic colorectal and breast cancer, PCS499 for Ulcerative Necrobiosis Lipoidica, and PCS12852 for gastroparesis and gastrointestinal motility disorders. Processa utilizes a regulatory science approach to efficiently advance its drug candidates through the development and approval process, with the goal of improving patient survival and quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Processa Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Processa Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Processa Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
